Aytu BioPharma (AYTU) Set to Announce Earnings on Thursday

Aytu BioPharma (NASDAQ:AYTU) is set to issue its quarterly earnings data after the market closes on Thursday, September 26th.

Aytu BioPharma Stock Performance

Shares of AYTU opened at $2.43 on Wednesday. Aytu BioPharma has a 52-week low of $1.55 and a 52-week high of $3.50. The firm has a market cap of $14.51 million, a price-to-earnings ratio of -0.92 and a beta of -1.43. The business’s fifty day moving average is $2.54 and its 200-day moving average is $2.83.

Aytu BioPharma Company Profile

Aytu Biopharma, Inc, a commercial-stage pharmaceutical company, focuses on commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates through two segments: Rx segment and Consumer Health segment. The Rx segment offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years and older, and Cotempla XR-ODT for patients from six to seventeen years old.